Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The FEBS Journal

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1742-4658.2008.06619.xPMID 18754772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice Published, JLR Papers in Press, October 24, 2007.

  2008cited by this paper
• Involvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance

  2007cited by this paper
• The adipocyte as an active participant in energy balance and metabolism.

  2007cited by this paper
• Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.

  2007cited by this paper
• LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice s⃞

  2006cited by this paper
• Endogenous ApoE Expression Modulates Adipocyte Triglyceride Content and Turnover

  2006cited by this paper
• Leptin and Hypertension in Obesity

  2006cited by this paper
• How Obesity Causes Diabetes: Not a Tall Tale

  2005cited by this paper
• The Gut and Energy Balance: Visceral Allies in the Obesity Wars

  2005cited by this paper
• Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.

  2005cited by this paper
• Generation of a Recombinant Apolipoprotein E Variant with Improved Biological Functions

  2005cited by this paper
• Actual causes of death in the United States, 2000.

  2004cited by this paper
• Apolipoprotein E

  2004cited by this paper
• Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity.

  2003cited by this paper
• Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.

  2003cited by this paper
• VLDL Induces Adipocyte Differentiation in ApoE-Dependent Manner

  2003cited by this paper
• Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature.

  2001cited by this paper
• Obesity hypertension: role of leptin and sympathetic nervous system.

  2001cited by this paper
• Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo

  2001cited by this paper
• Obesity in the new millennium

  2000cited by this paper
• Obesity as a medical problem

  2000cited by this paper
• Genetics of body-weight regulation

  2000cited by this paper
• Medicinal strategies in the treatment of obesity

  2000cited by this paper
• Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non‐insulin‐dependent diabetes mellitus

  1999cited by this paper
• Lipoproteins and atherogenesis.

  1998cited by this paper
• Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma.

  1998cited by this paper
• Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ

  1998cited by this paper
• Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM

  1997cited by this paper
• Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis*

  1997cited by this paper
• Mechanism of free fatty acid-induced insulin resistance in humans.

  1996cited by this paper
• Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions in Vitro and in Vivo*

  1996cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

  1995cited by this paper
• Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action

  1995cited by this paper
• Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.

  1995cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells (*)

  1995cited by this paper
• An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

  1995cited by this paper
• Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link

  1994cited by this paper
• Actual causes of death in the United States.

  1994cited by this paper
• Peroxisome proliferator-activated receptors: finding the orphan a home

  1994cited by this paper
• Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

  1994cited by this paper
• Actual causes of death in the United States.

  1993cited by this paper
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

  1993cited by this paper
• Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.

  1993cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Effect of cytokines on "de novo" lipid synthesis and hormone secretion by isolated human islets.

  1992cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Control of terminal differentiation of adipose precursor cells by glucocorticoids.

  1991cited by this paper
• Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.

  1990cited by this paper
• Prostacyclin as a potent effector of adipose-cell differentiation.

  1989cited by this paper
• Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.

  1988cited by this paper
• A receptor-mediated pathway for cholesterol homeostasis.

  1986cited by this paper
• Identification and DNA sequence of a human apolipoprotein E cDNA clone.

  1982cited by this paper
• Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.

  1982cited by this paper
• Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.

  1982cited by this paper
• Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.

  1982cited by this paper
• Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.

  1981cited by this paper
• Human apolipoprotein E isoprotein subclasses are genetically determined.

  1981cited by this paper
• Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein.

  1980cited by this paper
• Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.

  1980cited by this paper
• Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes.

  1980cited by this paper
• Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts.

  1976cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Controversy in Clinical Endocrinology Metabolic Syndrome: a Multiplex Cardiovascular Risk Factor Mets as a Multiplex Cardiovascular Risk Factor

  year unknowncited by this paper

• Novel carboxamide derivatives increase lipoprotein lipase gene expression in endothelial and adipose tissues of triton WR- 1339 induced hyperlipidemic rats

  2025cites this paper
• Exploring animal models and in vitro models for liver diseases: a review

  2025cites this paper
• Effect of diet and genotype on the lipidome of mice with altered lipoprotein metabolism

  2024cites this paper
• Generational Diet-Induced Obesity Remodels the Omental Adipose Proteome in Female Mice

  2024cites this paper
• Insights into the roles of Apolipoprotein E in adipocyte biology and obesity

  2024cites this paper
• Aster glehni Extract, Including Caffeoylquinic Acids as the Main Constituents, Induces PPAR β/δ-Dependent Muscle–Type Change and Myogenesis in Apolipoprotein E Knockout Mice

  2024cites this paper
• Genetic Insights into Obesity and Brain: Combine Mendelian Randomization Study and Gene Expression Analysis

  2023cites this paper
• Human APOE4 Protects High-Fat and High-Sucrose Diet Fed Targeted Replacement Mice against Fatty Liver Disease Compared to APOE3

  2023cites this paper
• Impact of Testosterone Deficiency on Adipose Tissue Metabolic Activity and Plasma Lipoprotein and Glucose Homeostasis: The Role of Apolipoprotein E2 and E4 Isoforms

  2022cites this paper
• Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice

  2022cites this paper
• Emerging role of carboxylesterases in nonalcoholic fatty liver disease.

  2022cites this paper
• Pcpe2, a Novel Extracellular Matrix Protein, Regulates Adipocyte SR-BI–Mediated High-Density Lipoprotein Uptake

  2021cites this paper
• Isoform and tissue dependent impact of apolipoprotein E on adipose tissue metabolic activation: The role of apolipoprotein A1.

  2020cites this paper
• Beyond the CNS: The many peripheral roles of APOE.

  2020cites this paper
• Tissue-specific Functional Interaction Between Apolipoproteins A1 and E in Cold-Induced Adipose Organ Mitochondrial Energy Metabolism.

  2020cites this paper
• Screening of House Dust from Chinese Homes for Chemicals with Liver X Receptors Binding Activities and Characterization of Atherosclerotic Activity Using an in Vitro Macrophage Cell Line and ApoE−/− Mice

  2019cites this paper
• Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice

  2019cites this paper
• Animal models of NAFLD from a hepatologist's point of view.

  2019cites this paper
• Simultaneous LC/MS/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma[S]

  2019cites this paper
• Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception

  2018cites this paper
• Resistance to diet induced obesity in the apolipoprotein E deficient mouse is associated with an attenuated transcriptional response in visceral fat

  2018cites this paper
• Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation.

  2018cites this paper
• The Synergistic Effects of APOE Genotype and Obesity on Alzheimer’s Disease Risk

  2018cites this paper
• New mechanistic insights on the metabolic-disruptor role of chlorpyrifos in apoE mice: a focus on insulin- and leptin-signalling pathways

  2018cites this paper
• Influencia del genotipo apoE en la expresión de efectos neuroconductuales derivados de la exposición postnatal a clorpirifós

  2017cites this paper
• Diet-Induced Obesity Does Not Alter Tigecycline Treatment Efficacy in Murine Lyme Disease

  2017cites this paper
• Atherogenesis and metabolic dysregulation in LDL receptor-knockout rats.

  2017cites this paper
• Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice

  2017cites this paper
• High-density lipoprotein (HDL) metabolism and bone mass.

  2017cites this paper
• Protective effect of betulinic acid on early atherosclerosis in diabetic apolipoprotein‐E gene knockout mice

  2017cites this paper
• Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice

  2017cites this paper
• The Effects of Obesity on Spine Surgery: A Systematic Review of the Literature

  2016cites this paper
• Apoe phenotype expression and its modulation by chlorpyrifos: new insights into gene - toxic interactions

  2016cites this paper
• Prolonged Intake of Dietary Lipids Alters Membrane Structure and T Cell Responses in LDLr−/− Mice

  2016cites this paper
• Proteomic Profile of Unstable Atheroma Plaque: Increased Neutrophil Defensin 1, Clusterin, and Apolipoprotein E Levels in Carotid Secretome.

  2016cites this paper
• Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice.

  2016cites this paper
• The effect of apolipoprotein E (APOE) genotype and long chain omega 3 fatty acids on body weight and inflammation

  2015cites this paper
• Apolipoprotein E (APOE) genotype regulates body weight and fatty acid utilization-Studies in gene-targeted replacement mice.

  2015cites this paper
• Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition.

  2015cites this paper
• Scavenger Receptor Class B Type I Regulates Plasma Apolipoprotein E Levels and Dietary Lipid Deposition to the Liver.

  2015cites this paper
• Chronic exposure to chlorpyrifos triggered body weight increase and memory impairment depending on human apoE polymorphisms in a targeted replacement mouse model.

  2015cites this paper
• Implicación del Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) en el remodelado vascular y cardiaco

  2015cites this paper
• Adulthood dietary exposure to a common pesticide leads to an obese-like phenotype and a diabetic profile in apoE3 mice.

  2015cites this paper
• Apolipoprotein E promotes lipid accumulation and differentiation in human adipocytes.

  2015cites this paper
• Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains

  2015cites this paper
• H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

  2014cites this paper
• Genetic variation at the CELF1 (CUGBP, elav‐like family member 1 gene) locus is genome‐wide associated with Alzheimer's disease and obesity

  2014cites this paper
• The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations

  2014cites this paper
• Impaired compensatory beta‐cell function and growth in response to high‐fat diet in LDL receptor knockout mice

  2014influential citation
• Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.

  2014cites this paper
• Rolle des Hepatoadipokins Chemerin in der Entstehung von Insulinresistenz, Dyslipidämie und Atherosklerose im Mausmodell

  2013influential citation
• Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice.

  2013cites this paper
• Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet.

  2013cites this paper
• Apolipoprotein A5 deficiency aggravates high‐fat diet‐induced obesity due to impaired central regulation of food intake

  2013cites this paper
• APOE ε 3 is an energy-thrifty allele – Studies on energy intake , fat storage and energy expenditure in gene targeted replacement mice

  2013cites this paper
• The involvement of modified lipids in vascular injury and disease

  2013cites this paper
• Central leptin and insulin administration modulates serum cytokine- and lipoprotein-related markers.

  2012cites this paper
• Apolipoprotein E Genotype: The Innocent Bystander or Active Bridge Between Metabolic Syndrome and Cognitive Impairment?

  2012cites this paper
• Functional interactions between peroxisome proliferator-activated receptor-gamma and polipoprotein E isoforms in the regulation of neural functions in models of insulin resistance-relevance to Alzheimer's disease

  2012cites this paper
• Role of Perivascular and Visceral Adipose Tissues in Murine Models of Obesity and Atherosclerosis: A Dissertation

  2012cites this paper
• Myeloid Deletion of Nuclear Factor Erythroid 2−Related Factor 2 Increases Atherosclerosis and Liver Injury

  2012cites this paper
• ApoE and the role of very low density lipoproteins in adipose tissue inflammation.

  2012cites this paper
• Apolipoprotein A-I Modulates Processes Associated with Diet-Induced Nonalcoholic Fatty Liver Disease in Mice

  2012cites this paper
• Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes.

  2012cites this paper
• Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility

  2011cites this paper
• Deficiency in apolipoprotein E has a protective effect on diet‐induced nonalcoholic fatty liver disease in mice

  2011cites this paper
• Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.

  2011cites this paper
• A segmental labeling strategy for unambiguous determination of domain–domain interactions of large multi-domain proteins

  2011cites this paper
• Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat

  2011cites this paper
• Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome

  2011cites this paper
• Cholesterol toxicity in pancreatic islets from LDL receptor-deficient mice. Reply to: de Souza JC, de Oliveira CAM, Carneiro EM et al. [letter]

  2010cites this paper
• Ldlr-/- mice display decreased susceptibility to Western-type diet-induced obesity due to increased thermogenesis.

  2010cites this paper
• Peroxisome proliferator activated receptor-gamma P465L mutation in diabetes and atherosclerosis

  2010cites this paper
• The low-density lipoprotein receptor knock-out mouse : a model for the study of energy balance

  2010influential citation
• Differential response of two models of genetically modified mice fed with high fat and cholesterol diets: relationship to the study of non-alcoholic steatohepatitis

  2010cites this paper
• APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population

  2010cites this paper
• Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls.

  2010cites this paper
• Mechanisms of obesity and related pathologies: Role of apolipoprotein E in the development of obesity

  2009cites this paper
• Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond This work was supported by National Institutes of Health Grant HL-042630. Published, JLR Papers in Press, December 5, 2008.

  2009cites this paper
• Androgen deficiency and atherosclerosis: The lipid link.

  2009cites this paper